Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancerJames L Gulley, Philip M Arlen, Anne Bastian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
A phase II clinical trial of sorafenib in androgen-independent prostate cancerWilliam L Dahut, Charity Scripture, Edwin Posadas, et al.Frontiers in Oncology|July 9, 2020
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian CancerKristen P Zeligs, Maria Pia Morelli, Justin M David, et al.Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.The Journal of Urology|August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategyPhilip M Arlen, Lisa Skarupa, Mary Pazdur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinomaJames L Gulley, Philip M Arlen, Kwong-Yok Tsang, et al.European Urology Oncology|October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with EnzalutamideShruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2011
A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancerMahsa Mohebtash, Kwong-Yok Tsang, Ravi A Madan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancerYang-Min Ning, James L Gulley, Philip M Arlen, et al.Pageof 18